Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Curcumin × Thoracic × Clear all

Phase

Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Thoracic 1 Gynecologic 1 Genitourinary 1 CNS 1

Conditions

Lung Neoplasms 1

Interventions

pembrolizumab 127 Carboplatin 117 Cisplatin 114 Pemetrexed 88 Paclitaxel 69 Nivolumab 59 Radiotherapy 58 Docetaxel 56 Erlotinib Hydrochloride 54 Gemcitabine 47 Etoposide 37 Bevacizumab 37 osimertinib 36 durvalumab 36 Cyclophosphamide 36 atezolizumab 31 Cetuximab 28 Radiosurgery 22 fludarabine 19 Magnetic Resonance Spectroscopy 19 Irinotecan 19 130-nm albumin-bound paclitaxel 18 Vinorelbine 17 Specimen Handling 17 Gefitinib 17 Everolimus 17 Topotecan 16 Radiation 16 Ipilimumab 16 Fluorouracil 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02321293 2015-09-02

CURCUMIN

Lady Davis Institute

Phase 1 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡